TY  - JOUR

T1  - Endocrine therapy in prostate cancer: Time for reappraisal of risks, benefits and cost-effectiveness?

JO  - British Journal of Cancer

UR  - http://eprints.whiterose.ac.uk/107753/

PY  - 2013/01/15

AU  - Bourke L

AU  - Kirkbride P

AU  - Hooper R

AU  - Rosario AJ

AU  - Chico TJA

AU  - Rosario DJ

ED  - 

DO  - DOI: 10.1038/bjc.2012.523

VL  - 108

IS  - 1

SP  - 9

EP  - 13

Y2  - 2024/12/22

ER  -